Capital Impact Advisors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Capital Impact Advisors’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-7,836	Closed	-$588K	–	296
2015 Q3	$588K	Hold	7,836	–	–	0.3%	136
2015 Q2	$590K	Hold	7,836	–	–	0.27%	170
2015 Q1	$393K	Buy	7,836 +3,254	+71%	+$137K	0.18%	211
2014 Q4	$159K	Hold	4,582	–	–	0.07%	155
2014 Q3	$150	Hold	4,582	–	–	﹤0.01%	142
2014 Q2	$176K	Buy	+4,582	New	+$160K	0.13%	115

Capital Impact Advisors's KYTH Position: Q4 2015 in Review

Capital Impact Advisors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 7,836 shares — an estimated $588K sold.

Capital Impact Advisors first reported a position in KYTH in Q2 2014 and held it in 6 quarters. The position peaked at $590K in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Capital Impact Advisors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Capital Impact Advisors sold 7,836 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $588K.
Capital Impact Advisors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2014 and held it in 6 quarters.
Capital Impact Advisors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $590K in Q2 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Capital Impact Advisors's 13F filing for Q4 2015, filed 11 Jan 2016.